336
Views
20
CrossRef citations to date
0
Altmetric
Research Articles

Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-d-glucose–positron emission tomography/computed tomography in mantle cell lymphoma?

, , , , , , , & show all
Pages 2484-2489 | Received 26 Sep 2013, Accepted 11 Dec 2013, Published online: 07 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Morgane Cheminant, Stephen Robinson, Vincent Ribrag, Steven Le Gouill, Felipe Suarez, Richard Delarue & Olivier Hermine. (2015) Prognosis and outcome of stem cell transplantation for mantle cell lymphoma. Expert Review of Hematology 8:4, pages 493-504.
Read now

Articles from other publishers (19)

Lindsay Hammons & Timothy S. Fenske. (2022) Treatment of Mantle Cell Lymphoma in the Frontline Setting: Are We Ready for a Risk-Adapted Approach?. Journal of Personalized Medicine 12:7, pages 1134.
Crossref
Kristina Noring, Mattias Carlsten, Kristina Sonnevi & Björn Engelbrekt Wahlin. (2021) The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome. BMC Cancer 21:1.
Crossref
Sergio Cortelazzo, Maurilio Ponzoni, Andrés J.M. Ferreri & Martin Dreyling. (2020) Mantle cell lymphoma. Critical Reviews in Oncology/Hematology 153, pages 103038.
Crossref
Domenico Albano, Giorgio Treglia, Maria Gazzilli, Elisabetta Cerudelli, Raffaele Giubbini & Francesco Bertagna. (2020) 18F-FDG PET or PET/CT in Mantle Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 20:7, pages 422-430.
Crossref
Tarec Christoffer El‐Galaly & Chan Yoon Cheah. (2020) Mantle cell lymphoma — where precision medicine based on response‐adapted treatment strategies could show its full worth. British Journal of Haematology 189:4, pages 600-602.
Crossref
Young‐Woo Jeon, Joo‐Hyun O, Kyung‐Sin Park, Gi June Min, Sung‐Soo Park, Jae‐Ho Yoon, Ki‐Seong Eom, Chang‐Ki Min & Seok‐Goo Cho. (2019) Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R‐CHOP. British Journal of Haematology 188:6, pages 860-871.
Crossref
Nasrin Ghesani, Somali Gavane, Anthony Hafez & Lale Kostakoglu. 2020. Clinical Nuclear Medicine. Clinical Nuclear Medicine 685 729 .
Domenico Albano, Riccardo Laudicella, Paola Ferro, Michela Allocca, Elisabetta Abenavoli, Ambra Buschiazzo, Alessia Castellino, Agostino Chiaravalloti, Annarosa Cuccaro, Lea Cuppari, Rexhep Durmo, Laura Evangelista, Viviana Frantellizzi, Sofya Kovalchuk, Flavia Linguanti, Giulia Santo, Matteo Bauckneht & Salvatore Annunziata. (2019) The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study. Cancers 11:12, pages 1831.
Crossref
Domenico Albano, Paola Ferro, Giovanni Bosio, Federico Fallanca, Alessandro Re, Alessandra Tucci, Andrés José Maria Ferreri, Piera Angelillo, Luigi Gianolli, Raffaele Giubbini & Francesco Bertagna. (2019) Diagnostic and Clinical Impact of Staging 18F-FDG PET/CT in Mantle-Cell Lymphoma: A Two-Center Experience. Clinical Lymphoma Myeloma and Leukemia 19:8, pages e457-e464.
Crossref
Domenico Albano, Giovanni Bosio, Nicola Bianchetti, Chiara Pagani, Alessandro Re, Alessandra Tucci, Raffaele Giubbini & Francesco Bertagna. (2019) Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma. Annals of Nuclear Medicine 33:7, pages 449-458.
Crossref
Clément Bailly, Thomas Carlier, Cyrille Touzeau, Nicolas Arlicot, Françoise Kraeber-Bodéré, Steven Le Gouill & Caroline Bodet-Milin. (2019) Interest of FDG-PET in the Management of Mantle Cell Lymphoma. Frontiers in Medicine 6.
Crossref
C. Bodet-Milin, E. Itti & P.Y. Salaün. (2019) Lymphomes. Médecine Nucléaire 43:1, pages 150-160.
Crossref
Adalgisa Condoluci, Davide Rossi, Emanuele Zucca & Franco Cavalli. (2018) Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma. Current Oncology Reports 20:10.
Crossref
Shawn Karls, Hina Shah & Heather Jacene. (2018) PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up. Seminars in Nuclear Medicine 48:1, pages 37-49.
Crossref
Dominick Lamonica, Daniel A. Graf, Mihaela C. Munteanu & Myron S. Czuczman. (2017) 18 F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine–Rituximab . Journal of Nuclear Medicine 58:1, pages 62-68.
Crossref
Stephen E. Spurgeon, Brian G. Till, Peter Martin, Andre H. Goy, Martin P. Dreyling, Ajay K. Gopal, Michael LeBlanc, John P. Leonard, Jonathan W. Friedberg, Lawrence Baizer, Richard F. Little, Brad S. Kahl & Mitchell R. Smith. (2016) Recommendations for Clinical Trial Development in Mantle Cell Lymphoma. Journal of the National Cancer Institute 109:1, pages djw263.
Crossref
Emily C. Ayers, Sara Fardin, Saeid Gholami, Abass Alavi & Anthony R. Mato. (2016) Personalized Management Approaches in Lymphoma. PET Clinics 11:3, pages 209-218.
Crossref
John P. Apostolidis, Maria G. Skilakaki & Alexandra V. Nikaki. 2016. PET/CT in Lymphomas. PET/CT in Lymphomas 183 195 .
Irit Avivi & Andre Goy. (2015) Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice. Clinical Cancer Research 21:17, pages 3853-3861.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.